Carina Bergfeldt’s ADHD series faces disclosure questions

An SVT series following presenter Carina Bergfeldt through an ADHD assessment has prompted questions about how public-service television separates personal health storytelling from clinical advice and commercial interests. #DSEngineNow
Listen to this articleNarrated - 9:12
The SVT Culture report says author Katarina Bjärvall believes the first-person format lacks critical distance and can resemble medicine advertising. SVT says the series is not investigative and includes people who use medication as well as people who do not.
Bjärvall also objected that viewers were not told that psychiatrist Lotta Borg Skoglund, an expert in the programme, is chief executive of a company that provides ADHD assessments. SVT says it knew about that role but did not consider an on-screen disclosure necessary for the programme’s narrative.
The argument lands amid a wider rise in treatment. Sweden’s National Board of Health and Welfare reported that the share of women using ADHD medication rose from 1.2 per cent in 2020 to 2.3 per cent in 2024. That trend does not settle the television debate; it explains why clear boundaries between testimony, medical expertise and commercial interests matter to viewers.


